Form D · Pharmaceuticals
QUINTESSENCE BIOSCIENCES INC
Madison, WI · CIK 0001142893
Offering snapshot reported Jun 26, 2012 · SEC filing
- Reported sold
- $1.49M Offering amount: $1.49M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 12, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2012 | Initial | $1,486,000 | No comparison | 20 | SEC filing |
| Feb 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 18, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-180307
Offering closed October 31, 2011
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Jun 26, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ralph Kauten | Director, Executive |
| Laura L. Kiessling | Director |
| Ronald T. Raines | Director |
| Laura E. Strong | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
505 South Rosa Rd
Madison, WI, 53719
Madison, WI, 53719